Source: Annual Congress 2012 - MS6 Severe asthma: diagnosis and treatment
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Chanez (Marseille, France). Biomarkers and personalised treatment. Annual Congress 2012 - MS6 Severe asthma: diagnosis and treatment

Member's Comments

No comment yet.

Related content which might interest you: Biomarkers and personalised medicine for asthma Source: Eur Respir J, 53 (1) 1802094; 10.1183/13993003.02094-2018 Year: 2019 Biomarkers for clinical management Source: International Congress 2017 – PG12 Life-threatening pulmonary infections Year: 2017 Response to pulmonary rehabilitation: toward personalised programmes? Source: Eur Respir J 2015; 46: 1538-1540 Year: 2015 Asthma-associated factors - Potential predictive markers for patients stratification, personalized treatments and prevention Source: International Congress 2016 – Asthma points to ponder Year: 2016 Application of biomarkers and patient characteristics to personalize asthma treatment for children Source: International Congress 2016 – Deep phenotyping to improve treatment outcomes in paediatric asthma Year: 2016 Biomarkers Source: Eur Respir Monogr 2013; 62: 90-95 Year: 2013 Biomarkers Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease Year: 2012 Biomarkers Source: Eur Respir Monogr 2016; 71: 122-142 Year: 2016 Lifestyle interventions in prevention and comprehensive management of COPD Source: Breathe, 14 (3) 186; 10.1183/20734735.018618 Year: 2018 CC3 Lung cancer: personalised treatment and palliative care  Source: Paris 2018 - Educational material Year: 2018 Biologics: current use and future applications for personalised therapy Source: Virtual Congress 2021 – Wheezing illnesses along the life span Year: 2021 Biomarkers in clinical decision making Source: Annual Congress 2012 - PG10 An update on mesothelioma diagnostics and treatment Year: 2012 From guidelines to personalized treatment of children with asthma Source: Virtual Congress 2020 – Which paediatric asthma guidelines are the most appropriate for children and adolescents? Year: 2020 Chronic cough: Are we integrating non-pharmacological therapies into treatment plans? Source: International Congress 2017 – Clinical challenges in chronic lung diseases Year: 2017 Efficacy of IP-10 as a biomarker for monitoring tuberculosis therapy Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 Tumour tissue sampling for lung cancer management in the era of personalised therapy: what is good enough for molecular testing? Source: Eur Respir J 2014; 44: 1011-1022 Year: 2014